Daiwa Securities Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Daiwa Securities Group’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-51	Closed	-$2K	–	1282
2025 Q4	$2K	Hold	51	–	–	﹤0.01%	1308
2025 Q3	$2K	Hold	51	–	–	﹤0.01%	1269
2025 Q2	$1K	Hold	51	–	–	﹤0.01%	1261
2025 Q1	$1K	Hold	51	–	–	﹤0.01%	1225
2024 Q4	$1K	Hold	51	–	–	﹤0.01%	1251
2024 Q3	$1K	Hold	51	–	–	﹤0.01%	1249
2024 Q2	$1K	Hold	51	–	–	﹤0.01%	1289
2024 Q1	$2K	Hold	51	–	–	﹤0.01%	1268
2023 Q4	$2K	Hold	51	–	–	﹤0.01%	1272
2023 Q3	$2K	Hold	51	–	–	﹤0.01%	1216
2023 Q2	$2K	Hold	51	–	–	﹤0.01%	1231
2023 Q1	$2K	Hold	51	–	–	﹤0.01%	1215
2022 Q4	$2K	Hold	51	–	–	﹤0.01%	1224
2022 Q3	$2K	Hold	51	–	–	﹤0.01%	1226
2022 Q2	$3K	Buy	51 +19	+59%	+$1.13K	﹤0.01%	1202
2022 Q1	$2K	Hold	32	–	–	﹤0.01%	1248
2021 Q4	$2K	Hold	32	–	–	﹤0.01%	1283
2021 Q3	$2K	Buy	32 +19	+146%	+$1.13K	﹤0.01%	1242
2021 Q2	$1K	Hold	13	–	–	﹤0.01%	1192
2021 Q1	$1K	Hold	13	–	–	﹤0.01%	1198
2020 Q4	$1K	Sell	13 -27	-68%	-$3.3K	﹤0.01%	1177
2020 Q3	$6K	Hold	40	–	–	﹤0.01%	1074
2020 Q2	$8K	Hold	40	–	–	﹤0.01%	1080
2020 Q1	$8K	Sell	40 -6	-13%	-$1.29K	﹤0.01%	1072
2019 Q4	$10K	Sell	46 -8	-15%	-$1.48K	﹤0.01%	1061
2019 Q3	$8K	Sell	54 -6	-10%	-$983	﹤0.01%	1043
2019 Q2	$8K	Hold	60	–	–	﹤0.01%	1066
2019 Q1	$7K	Hold	60	–	–	﹤0.01%	1055
2018 Q4	$6K	Hold	60	–	–	﹤0.01%	1039
2018 Q3	$7K	Hold	60	–	–	﹤0.01%	1064
2018 Q2	$6K	Hold	60	–	–	﹤0.01%	1084
2018 Q1	$6K	Buy	+60	New	+$6.47K	﹤0.01%	1062

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Daiwa Securities Group's LKFT Position: Q1 2026 in Review

Daiwa Securities Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 51 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in LKFT in Q1 2018 and held it in 32 quarters. The position peaked at $10K in Q4 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Daiwa Securities Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 51 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $2K.
Daiwa Securities Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 32 quarters.
Daiwa Securities Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $10K in Q4 2019.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.